Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
3,095 USD | -2,37% | +10,00% | -25,69% |
19/03 | LEAP THERAPEUTICS, INC. : Baird herhaalt koopadvies voor het aandeel | ZM |
18/03 | Leap Therapeutics dient $200 miljoen in bij de Shelf Registration voor Gemengde Effecten | MT |
Vakgebied
Aantal werknemers: 54
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Doug Onsi
CEO | Chief Executive Officer | 55 | 01-01-11 |
Chris Mirabelli
CHM | Chairman | 69 | 01-01-11 |
Jason Baum
CTO | Chief Tech/Sci/R&D Officer | 45 | 24-08-20 |
Michael Haas
CTO | Chief Tech/Sci/R&D Officer | - | - |
Cynthia Sirard
CTO | Chief Tech/Sci/R&D Officer | 54 | 01-01-12 |
Augustine Lawlor
COO | Chief Operating Officer | 67 | 01-01-16 |
General Counsel | 56 | 24-08-20 | |
Jonathan Miller
PRN | Corporate Officer/Principal | - | 01-01-20 |
Mark O’Mahony
PRN | Corporate Officer/Principal | 53 | 01-01-11 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Joseph Loscalzo
BRD | Director/Board Member | 72 | 01-01-16 |
Nissim Mashiach
BRD | Director/Board Member | 63 | 01-01-17 |
Chris Mirabelli
CHM | Chairman | 69 | 01-01-11 |
James Cavanaugh
BRD | Director/Board Member | 87 | 01-01-16 |
Thomas Dietz
BRD | Director/Board Member | 60 | 01-01-16 |
Doug Onsi
CEO | Chief Executive Officer | 55 | 01-01-11 |
Chris Richard
BRD | Director/Board Member | 54 | 17-01-23 |
Patricia Martin
BRD | Director/Board Member | 63 | 01-01-23 |
Richard Schilsky
BRD | Director/Board Member | 73 | 01-09-22 |
William Li
BRD | Director/Board Member | 61 | 01-01-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 38 261 130 | 32 139 737 ( 84,00 %) | 0 | 84,00 % |
Bedrijfsgegevens
Leap Therapeutics, Inc.
47 Thorndike Street Suite B1-1
02141, Cambridge
+617 714 0360
http://www.leaptx.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-25,69% | 81,16 mln. | |
-1,98% | 103 mld. | |
+0,33% | 95,71 mld. | |
+1,69% | 22,02 mld. | |
-17,29% | 20,9 mld. | |
-9,30% | 17,85 mld. | |
-41,01% | 16,21 mld. | |
-15,11% | 15,52 mld. | |
+3,67% | 13,86 mld. | |
+35,37% | 12,04 mld. |
- Beurs
- Aandelen
- Koers LPTX
- Onderneming Leap Therapeutics, Inc.